ABLIVA AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1902 SEK | +1.71% |
|
-1.04% | -22.53% |
| 05-23 | Abliva AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 05-21 | Transcript : Abliva AB - Special Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABLIVA AB | Bio Therapeutic Drugs | +1.71% | -1.04% | -22.53% | -12.15% | -84.36% | 23.78M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- ABLI Stock
- Charts Abliva AB
- Comparison Chart
